<!DOCTYPE html><html><head>   <meta>     <title>Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results</title>   </meta>   <style>
.youtube_player_container {
    position: relative;
    width: 50%;
    padding-bottom: 26.25%;
    /* background-color: yellow; */
}
.youtube_player_frame {
    position: absolute;
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    border: 0;
}
       </style></head><body><a href="index_1.html"><h2>Index</h2></a><a href="https://www.cnbc.com/2024/09/14/pfizers-cancer-cachexia-drug-shows-positive-midstage-trial-results.html"><div><img style="width:400px;height=300px" src="https://image.cnbcfm.com/api/v1/image/107366244-1706618176217-gettyimages-1971421128-pfizer33.jpeg?v=1726174909&w=1920&h=1080" /></div><h1>[1144890] Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results</h1></a><div></div><div>2024-09-14 12:45:01+00:00</div><div><pre>The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.</pre></div></body></html>